Vitamin D for Infants & Children: Dosing & Deficiency Guide

TL;DR

• All breastfed infants need 400 IU/day of cholecalciferol (vitamin D₃) starting within the first few days of life (AAP, NICE).
• Formula-fed infants receiving <1 L/day of formula also require supplementation.
• Vitamin D deficiency affects up to 15–40% of children worldwide, with darker skin, northern latitudes, and obesity increasing risk.
• Treatment doses for confirmed deficiency range from 2,000 IU/day (infants) to 6,000 IU/day (adolescents) for 6–12 weeks, depending on age and severity.
• Routine screening of 25(OH)D levels is not recommended for healthy children — test only those with risk factors or clinical signs.

---

What Is Vitamin D and Why Does It Matter in Children?

Vitamin D is a fat-soluble secosteroid that functions as a prohormone. The two principal forms — ergocalciferol (vitamin D₂) and cholecalciferol (vitamin D₃) — undergo sequential hydroxylation in the liver (to 25-hydroxyvitamin D [25(OH)D]) and kidneys (to the active metabolite 1,25-dihydroxyvitamin D [calcitriol]) before exerting biological effects.

In growing children, vitamin D plays a critical role in:

• Calcium and phosphorus homeostasis — enabling adequate bone mineralization
• Skeletal development — preventing rickets and osteomalacia
• Immune modulation — supporting innate and adaptive immune function
• Muscle function — deficiency is associated with proximal muscle weakness

Vitamin D dosing children guidelines exist because pediatric populations face distinct risks. Breast milk contains only 20–80 IU/L of vitamin D — far below the 400 IU/day an infant requires. Children with limited sun exposure, darker skin pigmentation, or certain chronic diseases cannot synthesize sufficient vitamin D cutaneously.

Epidemiology of Deficiency

Prevalence data vary by region and threshold used, but systematic reviews suggest that 15–40% of children globally have serum 25(OH)D levels below 50 nmol/L (20 ng/mL), the threshold most guidelines define as deficient. In northern European countries, winter prevalence of insufficiency (<75 nmol/L) can exceed 50% in adolescents. The Endocrine Society and AAP both identify pediatric vitamin D deficiency as a widespread and underdiagnosed public health concern.

---

Preventive Supplementation: Who Needs It and How Much

The cornerstone of pediatric vitamin D guidance is universal supplementation for infants and targeted supplementation for older children at risk. Below is a summary of current international recommendations for prevention.

Comparison of Major Guideline Recommendations

Breastfed Infants: The Critical Group

Every exclusively or partially breastfed infant should receive 400 IU/day of vitamin D₃ beginning in the first few days of life. This recommendation, established by the AAP and echoed by NICE, exists because human milk — despite its many nutritional advantages — does not deliver adequate vitamin D. The AAP advises continuation until the infant is weaned to ≥1 L/day (approximately 32 oz/day) of vitamin D–fortified formula or whole milk.

Practical points for parents:

• Liquid vitamin D₃ drops are available in concentrations of 400 IU per drop or per mL — always verify the product's concentration before administering.
• Drops can be placed directly on the infant's tongue, on the nipple before feeding, or mixed into a small volume of expressed breast milk.
• Consistency matters more than timing — the supplement can be given at any time of day.

Formula-Fed Infants

Standard infant formulas in the US and EU are fortified with approximately 400 IU/L of vitamin D. An infant consuming at least 1 L (≈32 oz) of formula daily generally receives adequate vitamin D and does not require additional supplementation. Infants taking less than this volume — including those receiving mixed breast milk and formula feeds — should receive supplemental vitamin D to make up the difference.

Children Aged 1–18 Years

For toddlers and older children, the AAP and Endocrine Society recommend at least 600 IU/day through diet and supplementation combined. NICE recommends 400 IU/day for all children aged 1–4 years and suggests that older children and adolescents consider supplementation during autumn and winter months (October–March in the Northern Hemisphere). In practice, most pediatric multivitamins contain 400–600 IU of vitamin D₃ per serving.

---

Dosing for Treatment of Confirmed Deficiency

When a child has documented vitamin D deficiency — defined as serum 25(OH)D <30 nmol/L (12 ng/mL) by most guidelines, or <50 nmol/L (20 ng/mL) by the Endocrine Society — treatment doses substantially exceed preventive doses. The goal is to replete stores rapidly and then transition to a maintenance regimen.

Cholecalciferol Pediatric Treatment Doses by Age

Sources: Endocrine Society 2011 & 2024 guidelines; Global Consensus on Rickets 2016.

Key clinical points:

• Cholecalciferol (vitamin D₃) is preferred over ergocalciferol (vitamin D₂) for treatment in children due to superior bioavailability and more sustained elevation of 25(OH)D levels.
• Recheck 25(OH)D levels after 6–12 weeks of treatment to confirm repletion (target: ≥50 nmol/L [20 ng/mL]; some guidelines prefer ≥75 nmol/L [30 ng/mL]).
• In infants <3 months, avoid high single-bolus ("stoss") dosing — daily regimens are safer and better studied in this age group.

---

When to Test: Indications for Measuring 25(OH)D

Routine screening of serum 25(OH)D is not recommended for healthy, asymptomatic children (AAP; Endocrine Society 2024). Universal screening is neither cost-effective nor supported by evidence of improved outcomes in the general pediatric population.

Testing is appropriate when a child has one or more of the following:

• Clinical signs of rickets — bowing of legs, widened wrists, frontal bossing, delayed fontanelle closure, poor linear growth
• Unexplained fractures or low bone mineral density on imaging
• Chronic diseases affecting absorption — celiac disease, inflammatory bowel disease, cystic fibrosis, short bowel syndrome
• Chronic kidney or liver disease
• Medications that accelerate vitamin D catabolism — phenobarbital, phenytoin, carbamazepine, rifampicin, certain antiretrovirals
• Obesity (BMI ≥95th percentile) — adipose tissue sequesters vitamin D, leading to lower circulating 25(OH)D
• Dark skin pigmentation combined with minimal sun exposure
• Prolonged exclusive breastfeeding without supplementation

Interpreting Results

---

Rickets: Prevention and Recognition

Nutritional rickets — the classic consequence of severe, prolonged vitamin D deficiency in growing children — remains a reality even in high-income countries. The Global Consensus on Rickets (2016) emphasized that 400 IU/day of vitamin D from birth effectively prevents nutritional rickets in virtually all infants, regardless of latitude or skin color.

Clinical Features of Rickets

• Skeletal: Craniotabes (softening of the skull in young infants), rachitic rosary (palpable enlargement of costochondral junctions), widened wrists and ankles, genu varum (bowlegs) or genu valgum (knock-knees), delayed closure of anterior fontanelle
• Growth: Poor linear growth, failure to thrive
• Muscular: Proximal weakness, delayed motor milestones, hypotonia
• Metabolic: Hypocalcemic seizures (particularly in infants aged 3–6 months), tetany
• Dental: Enamel hypoplasia, delayed eruption

Radiographic findings include metaphyseal fraying, cupping, and widening of the growth plates — most readily visualized at the wrist or knee.

Treatment of confirmed rickets requires both vitamin D repletion (at the treatment doses outlined above) and adequate calcium intake (at least 500 mg/day in children ≥1 year, per the Global Consensus). Calcium supplementation is often necessary alongside vitamin D, particularly in populations with habitually low dairy intake.

---

Special Populations and Higher Needs

Children with Obesity

Vitamin D deficiency is disproportionately common in children with obesity. Adipose tissue acts as a reservoir for this fat-soluble vitamin, reducing its bioavailability. The Endocrine Society recommends that children with obesity receive 2–3 times the standard age-based dose — both for prevention and treatment. For a child aged 1–12 years with obesity, this translates to a preventive dose of approximately 1,000–2,000 IU/day and treatment doses of 4,000–6,000 IU/day for 6–12 weeks.

Children with Malabsorptive Conditions

In celiac disease, inflammatory bowel disease, cystic fibrosis, and post-bariatric-surgery adolescents, intestinal absorption of vitamin D is impaired. These patients may require:

• Higher oral doses (2–4× standard)
• 25(OH)D monitoring every 3–6 months
• Occasionally, parenteral vitamin D (intramuscular cholecalciferol) in refractory cases

Children on Anticonvulsants

Enzyme-inducing anticonvulsants (phenobarbital, phenytoin, carbamazepine) upregulate hepatic CYP enzymes that accelerate the catabolism of 25(OH)D and 1,25(OH)₂D. The Endocrine Society recommends monitoring 25(OH)D levels in these patients and supplementing with at least 1,000–2,000 IU/day, adjusting based on serum levels.

Premature Infants

Premature infants (<37 weeks' gestation) have lower vitamin D stores at birth and higher metabolic demands during rapid postnatal growth. The AAP and ESPGHAN recommend 200–400 IU/day for very low birth weight infants (<1,500 g) and 400 IU/day for infants >1,500 g, initiated when enteral feeds are established. Specialized preterm formulas and human milk fortifiers typically contain vitamin D, but intake should be verified.

Dark-Skinned Children in Northern Latitudes

Melanin in the epidermis absorbs ultraviolet B radiation, reducing cutaneous vitamin D synthesis by up to 90% compared to fair-skinned individuals at equivalent sun exposure. Children of African, South Asian, or Middle Eastern descent living at latitudes above 35°N are at particular risk. Year-round supplementation at 400–1,000 IU/day is prudent, with a lower threshold for testing if symptoms or risk factors are present.

---

Safety, Side Effects, and Toxicity

Vitamin D supplementation at recommended doses is remarkably safe in children. Adverse effects at physiologic doses (400–1,000 IU/day) are essentially absent in the literature. Toxicity occurs only with sustained intake of grossly excessive amounts.

Vitamin D Toxicity — What Clinicians and Parents Should Know

• Threshold for concern: The Endocrine Society considers 4,000 IU/day the tolerable upper intake level (UL) for children aged 9–18 years; for infants 0–6 months, the UL is 1,000 IU/day; for children 1–3 years, 2,500 IU/day; and for children 4–8 years, 3,000 IU/day.
• Mechanism of toxicity: Hypervitaminosis D causes hypercalcemia and hyperphosphatemia. Calcium deposits in soft tissues (kidneys, blood vessels, heart) can result in nephrocalcinosis and, in extreme cases, renal failure.
• Clinical signs of toxicity: Anorexia, nausea, vomiting, polyuria, polydipsia, constipation, irritability, failure to thrive.
• Reported toxic levels: Serum 25(OH)D consistently >375 nmol/L (>150 ng/mL) is associated with hypercalcemia. Isolated elevated 25(OH)D without hypercalcemia may not require treatment beyond dose reduction.
• Most common cause in children: Dosing errors — particularly with highly concentrated liquid preparations. A product delivering 1,000 IU per drop can easily cause a 5- or 10-fold overdose if a parent assumes one dropperful equals one dose.

Safe supplementation practice: Use products specifically designed for infants and children, and verify the concentration on the label before each new bottle.

---

Drug and Nutrient Interactions

---

Red Flags — When to Seek Immediate Medical Attention

Parents and caregivers should seek urgent medical evaluation if a child receiving vitamin D supplementation — or suspected of deficiency — develops any of the following:

• Seizures — especially in young infants (may indicate hypocalcemia from severe deficiency)
• Persistent vomiting with excessive thirst and urination — may indicate vitamin D toxicity or hypercalcemia
• Bowing of the legs or visible skeletal deformities — suggestive of rickets
• Failure to thrive or growth arrest — warrants comprehensive evaluation including 25(OH)D, calcium, phosphorus, and alkaline phosphatase
• Unexplained fractures — consider both metabolic bone disease and non-accidental injury
• Muscle weakness or difficulty walking in a previously mobile child

---

Frequently Asked Questions

How much vitamin D does a breastfed baby need?

All exclusively or partially breastfed infants should receive 400 IU of vitamin D₃ daily, starting within the first few days of life. This is the consistent recommendation from the AAP, NICE, and WHO. Breast milk alone does not provide enough vitamin D regardless of the mother's diet or sun exposure.

Can I give my toddler too much vitamin D?

At recommended preventive doses (400–600 IU/day), toxicity is virtually impossible. However, errors can occur with concentrated supplements. Always use age-appropriate products, read the label carefully, and do not exceed 1,000 IU/day for children under 1 year or 2,500 IU/day for children aged 1–3 years without medical supervision.

Should I give vitamin D₂ or vitamin D₃?

Vitamin D₃ (cholecalciferol) is preferred. It is more effective at raising and maintaining serum 25(OH)D levels compared to vitamin D₂ (ergocalciferol). Most pediatric supplements and all international pediatric guidelines reference vitamin D₃.

Does my formula-fed baby need vitamin D drops?

Only if the baby is consuming less than approximately 1 liter (32 oz) of vitamin D–fortified formula per day. Most standard infant formulas contain about 400 IU/L, so a full day's feeds at adequate volume will meet the requirement. Newborns and young infants who have not yet reached this intake volume should receive supplemental drops.

When should my child's vitamin D level be checked?

Routine blood testing is not recommended for healthy children. Testing is indicated when risk factors (obesity, malabsorption, dark skin with limited sun exposure, anticonvulsant use) or clinical signs (skeletal deformity, unexplained fractures, poor growth) are present. Discuss with your pediatrician if you are uncertain.

Is sun exposure enough to prevent vitamin D deficiency?

For many children, it is not reliably sufficient — particularly those living at latitudes above 35°, with dark skin pigmentation, or who regularly use sunscreen. Dermatology guidelines appropriately discourage unprotected sun exposure in children due to skin cancer risk. Supplementation remains the safest and most reliable strategy.

My child has obesity — does the dose change?

Yes. Children with obesity (BMI ≥95th percentile for age) typically require 2–3 times the standard dose because vitamin D is sequestered in adipose tissue. This applies to both preventive and treatment dosing. The Endocrine Society specifically addresses this population in its 2024 guideline.

Can vitamin D help prevent my child from getting sick?

Observational studies and some meta-analyses suggest a modest protective effect of adequate vitamin D status against acute respiratory infections in children. However, the evidence is not strong enough for any guideline body to recommend vitamin D supplementation primarily for infection prevention. The primary indication remains bone health.

---

References

1. Wagner CL, Greer FR; Section on Breastfeeding and Committee on Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122(5):1142–1152. PMID: 18977996

2. Munns CF, Shaw N, Kiely M, et al. Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab. 2016;101(2):394–415. PMID: 26745253

3. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. PMID: 21646368

4. Demay MB, Pittas AG, Kienreich K, et al. Vitamin D for the prevention of disease: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2024;109(7):1907–1947. PMID: 38828931

5. NICE. Vitamin D: supplement use in specific population groups. Public health guideline PH56. 2014 (updated 2017). nice.org.uk/guidance/ph56

6. Golden NH, Abrams SA; Committee on Nutrition. Optimizing bone health in children and adolescents. Pediatrics. 2014;134(4):e1229–e1243. PMID: 25266429

7. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. PMID: 28202713

8. Misra M, Pacaud D, Petryk A, et al. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008;122(2):398–417. PMID: 18676559

9. CDC. Vitamin D fact sheet for health professionals. National Institutes of Health Office of Dietary Supplements. 2024. ods.od.nih.gov/factsheets/VitaminD-HealthProfessional

---

About the Author

Dr. Stanislav Ozarchuk, PharmD, is a clinical pharmacist with 15 years of experience spanning hospital pharmacy, ambulatory care, and medication safety. He holds a Doctor of Pharmacy degree and has provided drug information consulting across pediatric, obstetric, and general internal medicine settings. As a contributor to PillsCard.com, Dr. Ozarchuk translates complex pharmacological evidence into accessible, rigorously sourced guides for patients and healthcare professionals worldwide. His work emphasizes evidence-based practice, drawing on guidelines from the AAP, NICE, Endocrine Society, WHO, and other authoritative bodies.

---

Medical Disclaimer

This article is intended for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. The information presented reflects published clinical guidelines and peer-reviewed evidence as of the date of publication but should not replace individualized guidance from a qualified healthcare provider. Always consult your child's pediatrician, family physician, or pharmacist before starting, stopping, or changing any medication or supplement — including vitamin D. If your child is experiencing symptoms of deficiency or toxicity, seek prompt medical evaluation. PillsCard.com and the author assume no liability for actions taken based on the content of this article.